It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BWAY’s FA Score shows that 0 FA rating(s) are green whileCODX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BWAY’s TA Score shows that 3 TA indicator(s) are bullish while CODX’s TA Score has 5 bullish TA indicator(s).
BWAY (@Medical/Nursing Services) experienced а -5.24% price change this week, while CODX (@Medical/Nursing Services) price change was -12.47% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.97%. For the same industry, the average monthly price growth was +2.80%, and the average quarterly price growth was +8.73%.
BWAY is expected to report earnings on Nov 12, 2025.
CODX is expected to report earnings on Nov 06, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
BWAY | CODX | BWAY / CODX | |
Capitalization | 279M | 18.5M | 1,508% |
EBITDA | 8.3M | -37.47M | -22% |
Gain YTD | 55.461 | -48.893 | -113% |
P/E Ratio | 52.36 | N/A | - |
Revenue | 46.1M | 1M | 4,592% |
Total Cash | 78M | 13.4M | 582% |
Total Debt | 6.13M | 1.7M | 360% |
BWAY | CODX | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 87 | 49 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 54 Fair valued | |
PROFIT vs RISK RATING 1..100 | 57 | 100 | |
SMR RATING 1..100 | 72 | 98 | |
PRICE GROWTH RATING 1..100 | 42 | 45 | |
P/E GROWTH RATING 1..100 | 100 | 16 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CODX's Valuation (54) in the Biotechnology industry is in the same range as BWAY (77) in the Medical Specialties industry. This means that CODX’s stock grew similarly to BWAY’s over the last 12 months.
BWAY's Profit vs Risk Rating (57) in the Medical Specialties industry is somewhat better than the same rating for CODX (100) in the Biotechnology industry. This means that BWAY’s stock grew somewhat faster than CODX’s over the last 12 months.
BWAY's SMR Rating (72) in the Medical Specialties industry is in the same range as CODX (98) in the Biotechnology industry. This means that BWAY’s stock grew similarly to CODX’s over the last 12 months.
BWAY's Price Growth Rating (42) in the Medical Specialties industry is in the same range as CODX (45) in the Biotechnology industry. This means that BWAY’s stock grew similarly to CODX’s over the last 12 months.
CODX's P/E Growth Rating (16) in the Biotechnology industry is significantly better than the same rating for BWAY (100) in the Medical Specialties industry. This means that CODX’s stock grew significantly faster than BWAY’s over the last 12 months.
BWAY | CODX | |
---|---|---|
RSI ODDS (%) | 3 days ago82% | 3 days ago90% |
Stochastic ODDS (%) | 3 days ago82% | 3 days ago75% |
Momentum ODDS (%) | 3 days ago82% | 3 days ago83% |
MACD ODDS (%) | 3 days ago84% | 3 days ago84% |
TrendWeek ODDS (%) | 3 days ago80% | 3 days ago86% |
TrendMonth ODDS (%) | 3 days ago77% | 3 days ago82% |
Advances ODDS (%) | 20 days ago85% | 10 days ago80% |
Declines ODDS (%) | 5 days ago77% | 6 days ago87% |
BollingerBands ODDS (%) | 3 days ago84% | 3 days ago87% |
Aroon ODDS (%) | 3 days ago88% | 3 days ago84% |
A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with STIM. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then STIM could also see price increases.
Ticker / NAME | Correlation To BWAY | 1D Price Change % | ||
---|---|---|---|---|
BWAY | 100% | -1.68% | ||
STIM - BWAY | 34% Loosely correlated | +1.50% | ||
BFLY - BWAY | 30% Poorly correlated | +2.55% | ||
ITGR - BWAY | 30% Poorly correlated | -0.27% | ||
ISRG - BWAY | 29% Poorly correlated | +0.68% | ||
CODX - BWAY | 28% Poorly correlated | +2.16% | ||
More |
A.I.dvisor tells us that CODX and ALGN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CODX and ALGN's prices will move in lockstep.
Ticker / NAME | Correlation To CODX | 1D Price Change % | ||
---|---|---|---|---|
CODX | 100% | +2.16% | ||
ALGN - CODX | 33% Poorly correlated | +1.05% | ||
NVST - CODX | 32% Poorly correlated | +1.80% | ||
INBS - CODX | 30% Poorly correlated | -12.50% | ||
MBOT - CODX | 30% Poorly correlated | -2.13% | ||
AIMD - CODX | 28% Poorly correlated | -0.85% | ||
More |